Evidence map›Paper›PMID 31551950›Full record

ArticleFrontiers in microbiology2019

Bacteriophages Reduce Pathogenic

Upuli Dissanayake, Maria Ukhanova, Zachary Daniel Moye, Alexander Sulakvelidze, Volker Mai

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Investigating the novel Escherichia coli bacteriophage Jgk1 as a potential antimicrobial agent.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  9. Shiga toxin-producingMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  10. Review
  11. vB_EcoM-P896 coliphage isolated from duck sewage can lyse both intestinal pathogenic Escherichia coli and extraintestinal pathogenic E. coli.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Modulation of Caecal Microbiota and Metabolome Profile inInternational journal of molecular sciences · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Upuli DissanayakeDepartment of Epidemiology, College of Medicine, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States.
Maria UkhanovaLaboratory 300B, Department of Epidemiology, Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States.
Zachary Daniel MoyeIntralytix, Inc., Baltimore, MD, United States.
Alexander SulakvelidzeIntralytix, Inc., Baltimore, MD, United States.
Volker MaiDepartment of Epidemiology, College of Medicine, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States.
University of Florida · USIntralytix (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed a study to (i) investigate efficacy of an

Indexed as

bacteriophageE. colifoodborne diseasemicrobiomephage

Identifiers

PMID31551950
PMCPMC6748168
OpenAlexW2967288834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.